BME · BlackRock Health Sciences Trust · Fund Holdings
Market Cap
$615.45M
Shares
12.92M
Volume · Nov 12
24.48K
Avg daily vol (3M)
41.96K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.
BlackRock Health Sciences Trust
Reported 2026-06-30Net Assets
$571,466,391
Total Assets
$573,632,228
Holdings
156
Filed
2026-08-25
| Holding | CUSIP | Balance | Units | Value | % Net Assets | Category | Country |
|---|---|---|---|---|---|---|---|
| Eli Lilly & Co | 532457108 | 59,379 | NS | $71,220,954 | 12.46% | EC | US |
| Johnson & Johnson | 478160104 | 175,604 | NS | $44,598,148 | 7.80% | EC | US |
| UnitedHealth Group Inc | 91324P102 | 84,166 | NS | $34,981,915 | 6.12% | EC | US |
| Merck & Co Inc | 58933Y105 | 232,628 | NS | $29,892,698 | 5.23% | EC | US |
| AbbVie Inc | 00287Y109 | 115,083 | NS | $28,959,486 | 5.07% | EC | US |
| Gilead Sciences Inc | 375558103 | 166,662 | NS | $21,056,077 | 3.68% | EC | US |
| Amgen Inc | 031162100 | 53,219 | NS | $19,271,664 | 3.37% | EC | US |
| BlackRock Liquidity Funds | 09248U718 | 19,047,042 | NS | $19,047,042 | 3.33% | STIV | US |
| Thermo Fisher Scientific Inc | 883556102 | 33,830 | NS | $16,961,009 | 2.97% | EC | US |
| Vertex Pharmaceuticals Inc | 92532F100 | 31,983 | NS | $15,886,916 | 2.78% | EC | US |
| Edwards Lifesciences Corp | 28176E108 | 149,905 | NS | $13,560,406 | 2.37% | EC | US |
| Danaher Corp | 235851102 | 57,611 | NS | $10,973,743 | 1.92% | EC | US |
| Abbott Laboratories | 002824100 | 119,561 | NS | $10,848,965 | 1.90% | EC | US |
| Elevance Health Inc | 036752103 | 27,515 | NS | $10,640,876 | 1.86% | EC | US |
| Pfizer Inc | 717081103 | 354,263 | NS | $8,530,653 | 1.49% | EC | US |
| Argenx SE | 04016X101 | 8,058 | NS | $7,475,971 | 1.31% | EC | NL |
| Boston Scientific Corp | 101137107 | 173,789 | NS | $7,417,315 | 1.30% | EC | US |
| Biogen Inc | 09062X103 | 31,869 | NS | $6,885,616 | 1.20% | EC | US |
| Teva Pharmaceutical Industries Ltd | 881624209 | 195,347 | NS | $6,618,356 | 1.16% | EC | IL |
| Intuitive Surgical Inc | 46120E602 | 16,457 | NS | $6,544,620 | 1.15% | EC | US |
| Stryker Corp | 863667101 | 19,938 | NS | $6,277,280 | 1.10% | EC | US |
| Revolution Medicines Inc | 76155X100 | 32,101 | NS | $6,011,875 | 1.05% | EC | US |
| Moderna Inc | 60770K107 | 81,325 | NS | $5,695,190 | 1.00% | EC | US |
| Waters Corp | 941848103 | 15,073 | NS | $5,652,978 | 0.99% | EC | US |
| Cytokinetics Inc | 23282W605 | 59,440 | NS | $5,063,694 | 0.89% | EC | US |
| Regeneron Pharmaceuticals Inc | 75886F107 | 7,712 | NS | $4,808,740 | 0.84% | EC | US |
| Bristol-Myers Squibb Co | 110122108 | 81,467 | NS | $4,694,129 | 0.82% | EC | US |
| CVS Health Corp | 126650100 | 41,701 | NS | $4,313,968 | 0.75% | EC | US |
| Humana Inc | 444859102 | 10,819 | NS | $4,297,523 | 0.75% | EC | US |
| AstraZeneca PLC | 000000000 | 22,678 | NS | $4,234,078 | 0.74% | EC | GB |
| Cogent Biosciences Inc | 19240Q201 | 103,620 | NS | $4,010,094 | 0.70% | EC | US |
| HCA Healthcare Inc | 40412C101 | 10,127 | NS | $3,948,416 | 0.69% | EC | US |
| Incyte Corp | 45337C102 | 34,568 | NS | $3,918,628 | 0.69% | EC | US |
| Dexcom Inc | 252131107 | 57,910 | NS | $3,900,239 | 0.68% | EC | US |
| Galderma Group AG | 000000000 | 16,599 | NS | $3,775,400 | 0.66% | EC | CH |
| Penumbra Inc | 70975L107 | 11,606 | NS | $3,664,595 | 0.64% | EC | US |
| Protagonist Therapeutics Inc | 74366E102 | 29,705 | NS | $3,641,239 | 0.64% | EC | US |
| Nuvalent Inc | 670703107 | 28,618 | NS | $3,534,323 | 0.62% | EC | US |
| Novartis AG | 66987V109 | 21,810 | NS | $3,418,063 | 0.60% | EC | CH |
| Insmed Inc | 457669307 | 30,918 | NS | $3,296,477 | 0.58% | EC | US |
| Agilent Technologies Inc | 00846U101 | 23,884 | NS | $3,172,512 | 0.56% | EC | US |
| Apogee Therapeutics Inc | 03770N101 | 23,470 | NS | $3,115,173 | 0.55% | EC | US |
| IDEXX Laboratories Inc | 45168D104 | 5,896 | NS | $3,103,890 | 0.54% | EC | US |
| Rhythm Pharmaceuticals Inc | 76243J105 | 27,009 | NS | $2,998,809 | 0.52% | EC | US |
| United Therapeutics Corp | 91307C102 | 4,903 | NS | $2,656,592 | 0.46% | EC | US |
| Illumina Inc | 452327109 | 14,875 | NS | $2,615,471 | 0.46% | EC | US |
| Alnylam Pharmaceuticals Inc | 02043Q107 | 8,378 | NS | $2,522,029 | 0.44% | EC | US |
| IQVIA Holdings Inc | 46266C105 | 12,502 | NS | $2,415,636 | 0.42% | EC | US |
| Oruka Therapeutics Inc | 687604108 | 23,783 | NS | $2,263,428 | 0.40% | EC | US |
| Bruker Corp | 116794108 | 36,061 | NS | $2,170,151 | 0.38% | EC | US |
Showing 1–50 of 156 holdings